Clinical Trials Logo
  1. Home
  2. Minimal Hepatic Encephalopathy
  3. NCT01069133

Study of Rifaximin in Minimal Hepatic Encephalopathy

Minimal Hepatic Encephalopathy Clinical Trial

Official title:
Effect of Rifaximin Therapy on Brain Activation in Patients With Minimal Hepatic Encephalopathy Using Functional MR, MR Spectroscopy,Diffusion Tensor Imaging Microbiome and Metabolome: a Prospective Trial

Clinical Trial Summary

Rifaximin therapy will improve brain functioning on MRI scanning and change the microbiome and metabolome.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01069133
Study type Interventional
Source Hunter Holmes Mcguire Veteran Affairs Medical Center
Contact
Status Completed
Phase Phase 1/Phase 2
Start date February 2010
Completion date December 2012
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Completed NCT00992290 - Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy Phase 1
Completed NCT00312078 - Effect of Yogurt on Minimal Hepatic Encephalopathy N/A
Recruiting NCT04058327 - A Study of MHE in Patients With Liver Diseases
Completed NCT02767622 - Reversibility of Minimal Hepatic Encephalopathy Following Liver Transplantation N/A
Completed NCT03585257 - HEAL STUDY (Hepatic Encephalopathy and Albumin Study) Phase 2
Recruiting NCT01083446 - A Nutritional Approach to Minimal Hepatic Encephalopathy N/A
Completed NCT02520817 - Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study N/A
Terminated NCT00811434 - Study of Lactulose in Children With Chronic Liver Disease Phase 2
Completed NCT00375375 - Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life Phase 4
Completed NCT04077125 - Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy
Completed NCT01847651 - Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate Phase 4
Completed NCT01135628 - Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy N/A
Completed NCT01223729 - Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy N/A